Niederhuber John
Insider CIK 1501240 · EBS Director · APVO Board of Directors, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | — | 400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 7,200 | — | $0 | 7,200 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 1 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 925 | — | $0 | 925 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 217 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 136 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 5,682 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 298 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 2,111 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 595 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 1,814 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 2,678 | — | $0 | 2,678 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 893 | — | $0 | 893 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 170 | — | $0 | 170 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,339 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 892 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,785 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 1,322 | — | $0 | 1,322 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-02 | 2021-02-17 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-06-14 | 2022-06-03 | 714 | $0.91 | $650 | 1,516 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-06-01 | 2019-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 18,750 | — | $0 | 18,750 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2016-05-18 | 2016-05-20 | 7,833 | — | $0 | 22,467 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2016-05-18 | 2016-05-23 | 7,833 | — | $0 | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2015-05-21 | 2015-05-21 | 9,400 | — | $0 | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2014-05-22 | 2014-05-23 | 9,400 | — | $0 | 9,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-05-22 | 2014-05-23 | 4,700 | — | $0 | 20,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2013-05-23 | 2013-05-24 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-05-23 | 2013-05-24 | 3,600 | — | $0 | 16,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2012-05-17 | 2012-05-21 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2012-05-17 | 2012-05-21 | 3,600 | — | $0 | 12,600 | SEC↗ |